Archford Capital Strategies LLC lifted its holdings in Cerner Co. (NASDAQ:CERN) by 1,286.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,980 shares of the company’s stock after buying an additional 2,765 shares during the quarter. Archford Capital Strategies LLC’s holdings in Cerner were worth $213,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Alps Advisors Inc. boosted its position in Cerner by 0.3% during the second quarter. Alps Advisors Inc. now owns 8,693 shares of the company’s stock worth $578,000 after purchasing an additional 23 shares in the last quarter. Laurel Wealth Advisors Inc. boosted its position in Cerner by 0.6% during the second quarter. Laurel Wealth Advisors Inc. now owns 3,909 shares of the company’s stock worth $259,000 after purchasing an additional 24 shares in the last quarter. Conning Inc. boosted its position in Cerner by 0.8% during the second quarter. Conning Inc. now owns 7,742 shares of the company’s stock worth $515,000 after purchasing an additional 58 shares in the last quarter. ProVise Management Group LLC boosted its position in Cerner by 1.3% during the second quarter. ProVise Management Group LLC now owns 5,184 shares of the company’s stock worth $345,000 after purchasing an additional 69 shares in the last quarter. Finally, Advisory Services Network LLC boosted its position in Cerner by 4.4% during the second quarter. Advisory Services Network LLC now owns 1,648 shares of the company’s stock worth $110,000 after purchasing an additional 70 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

A number of research firms have commented on CERN. Jefferies Group set a $79.00 target price on Cerner and gave the stock a “buy” rating in a research report on Friday, October 13th. SunTrust Banks restated a “buy” rating and issued a $75.00 price objective on shares of Cerner in a research report on Monday, October 30th. Royal Bank of Canada assumed coverage on Cerner in a research report on Tuesday, September 19th. They issued a “top pick” rating and a $84.00 price objective on the stock. KeyCorp restated a “buy” rating and issued a $76.00 price objective on shares of Cerner in a research report on Friday, September 22nd. Finally, Robert W. Baird upgraded Cerner from a “neutral” rating to an “outperform” rating and upped their price objective for the company from $67.00 to $76.00 in a research report on Tuesday, October 31st. One analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and nine have issued a buy rating to the company’s stock. Cerner presently has a consensus rating of “Hold” and an average target price of $69.50.

In related news, CFO Marc G. Naughton sold 60,000 shares of the company’s stock in a transaction on Thursday, November 30th. The stock was sold at an average price of $70.64, for a total value of $4,238,400.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Clifford W. Illig sold 140,000 shares of the company’s stock in a transaction on Thursday, November 16th. The shares were sold at an average price of $65.52, for a total value of $9,172,800.00. Following the completion of the transaction, the chief executive officer now owns 1,229,719 shares of the company’s stock, valued at $80,571,188.88. The disclosure for this sale can be found here. Insiders sold 788,000 shares of company stock valued at $52,190,800 over the last quarter. Insiders own 13.11% of the company’s stock.

Cerner Co. (NASDAQ CERN) opened at $68.57 on Friday. The company has a market capitalization of $23,388.71, a price-to-earnings ratio of 31.13, a P/E/G ratio of 2.27 and a beta of 0.94. Cerner Co. has a 12 month low of $47.09 and a 12 month high of $73.86. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.77 and a quick ratio of 2.75.

Cerner (NASDAQ:CERN) last released its earnings results on Thursday, October 26th. The company reported $0.61 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.62 by ($0.01). The business had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.29 billion. Cerner had a net margin of 13.37% and a return on equity of 18.03%. The business’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.59 earnings per share. equities analysts predict that Cerner Co. will post 2.25 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This story was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this story can be viewed at https://www.thecerbatgem.com/2017/12/15/archford-capital-strategies-llc-has-213000-position-in-cerner-co-cern.html.

Cerner Company Profile

Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.

Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Co. (NASDAQ:CERN).

Institutional Ownership by Quarter for Cerner (NASDAQ:CERN)

Receive News & Stock Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related stocks with our FREE daily email newsletter.